Henry Doggrell
General Counsel at Union Main Management LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Hanover | M | - |
Union Main Management LLC
 Union Main Management LLC Investment ManagersFinance Union Main Management LLC (Union Main Group) is a private equity firm founded in 2020 by Adam Hanover, Marc Hanover and William Conway. The firm is headquartered in Memphis, Tennessee. | 4 years |
| Marc Hanover | M | 61 |
Union Main Management LLC
Union Main Management LLC Investment ManagersFinance Union Main Management LLC (Union Main Group) is a private equity firm founded in 2020 by Adam Hanover, Marc Hanover and William Conway. The firm is headquartered in Memphis, Tennessee. | 4 years |
| William Conway | M | 74 |
Union Main Management LLC
Union Main Management LLC Investment ManagersFinance Union Main Management LLC (Union Main Group) is a private equity firm founded in 2020 by Adam Hanover, Marc Hanover and William Conway. The firm is headquartered in Memphis, Tennessee. | - |
| Kenneth G. Elzinga | M | - |
University of Virginia
| 57 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mitchell Steiner | M | 63 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 17 years |
| Mark Mosteller | M | 61 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 12 years |
| Jason Shackelford | M | 48 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
| B. M. Cavaney | M | 81 |
Georgia-Pacific Nonwovens LLC
 Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | 17 years |
| Raymond Mabus | M | 75 |
Baker, Donelson, Bearman, Caldwell & Berkowitz PC
 Baker, Donelson, Bearman, Caldwell & Berkowitz PC Miscellaneous Commercial ServicesCommercial Services Baker, Donelson, Bearman, Caldwell & Berkowitz PC provides legal services. Its practice areas include litigation, corporate law, mergers and acquisitions, labor and employment, real estate, bankruptcy, health law, intellectual property, and tax law. The company was founded by James F. Baker in 1888 and is headquartered in Memphis, TN. | - |
| Katherine Gibson | F | 61 |
Georgia-Pacific Nonwovens LLC
Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | 8 years |
| John B. Crowe | M | 77 |
Georgia-Pacific Nonwovens LLC
Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | 16 years |
| Michael Carter | M | 86 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
| Chip W. Brown | M | - |
Vanderbilt University
University of Virginia
| 17 years |
| J. Thomas Smith | M | 74 |
Vanderbilt University
| 8 years |
| Charles W. Magee | M | - |
University of Virginia
| 8 years |
| Reynold Levy | M | 78 |
University of Virginia
| 5 years |
| Stuart M. Pape | M | - |
University of Virginia
| 7 years |
| George W. Logan | M | 79 |
University of Virginia
| 7 years |
| Robert G. Byron | M | - |
University of Virginia
| 7 years |
| Garry Neil | M | 70 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 3 years |
| Kenneth Jones | M | 75 |
University of Virginia
| 6 years |
| Thomas Napier Gordon | M | 72 |
Vanderbilt University
| 7 years |
| Chin Hock Ow | M | 79 |
Vanderbilt University
| 5 years |
| Brian K. Burke | M | - |
Vanderbilt University
| 7 years |
| Domingo Rodriguez | M | 62 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 9 years |
| George W. Bryan | M | 79 |
Georgia-Pacific Nonwovens LLC
Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | 12 years |
| Samuel W. Bartholomew | M | 78 |
Vanderbilt University
| 3 years |
| J. Glass | M | 77 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
| Robert Karr | M | 75 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 6 years |
| Vic A. Bell | M | - |
University of Virginia
| 6 years |
| James Aylor | M | - |
University of Virginia
| 6 years |
| R. Howard Cannon | M | 62 |
Georgia-Pacific Nonwovens LLC
Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | 17 years |
| Sheila Jordan Cunningham | F | 72 |
Georgia-Pacific Nonwovens LLC
Georgia-Pacific Nonwovens LLC Pulp & PaperProcess Industries Buckeye Technologies LLC manufactures and commercializes pulp and chemical cellulose products. The company was founded on January 26, 1993 and is headquartered in Atlanta, GA. | - |
| John Pontius | M | 68 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 13 years |
| Frank O. Clark | M | - |
University of Virginia
| 3 years |
| Timothy Sear | M | 86 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 9 years |
| James Dalton | M | 61 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 9 years |
| Barrington John Albert Furr | M | 80 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 4 years |
| Kenneth Robinson | M | 69 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
| Jeffrey G. Hesselberg | M | 65 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
| Ernest K. Hauser | M | - |
University of Virginia
| 4 years |
| Bill Miller | M | - |
University of Virginia
| 4 years |
| Steve Johnson | M | - |
University of Virginia
| 4 years |
| Norris Royston | M | 76 |
University of Virginia
| 4 years |
| Bob Wood | M | - |
University of Virginia
| 4 years |
| Kirk M. Hudson | M | - |
University of Virginia
| 4 years |
| John Moritz | M | - |
University of Virginia
| 4 years |
| John H. Moore | M | - |
University of Virginia
| 3 years |
| James T. Harvey | M | - |
University of Virginia
| 4 years |
| Paul Michel | M | - |
University of Virginia
| 3 years |
| Terry C. Bridges | M | - |
University of Virginia
| 3 years |
| Patrick L. Whitlow | M | - |
University of Virginia
| 4 years |
| Vera Vaswani Chawla | F | - |
University of Virginia
| 4 years |
| James M. Stelling | M | - |
University of Virginia
| 4 years |
| Nicholas Greksouk | M | - |
University of Virginia
| 4 years |
| Ernest Dempsey | M | - |
University of Virginia
| 4 years |
| Frances D. McMullan | M | - |
University of Virginia
| 4 years |
| Ellis Gedney | M | - |
University of Virginia
| 3 years |
| Thomas L. Mifflin | M | - |
University of Virginia
| 4 years |
| John L. Gainer | M | 85 |
University of Virginia
| 39 years |
| Douglas D. Blevins | M | - |
University of Virginia
| 4 years |
| Michael B. Packard | M | - |
University of Virginia
| 2 years |
| Robert J. Reger | M | - |
University of Virginia
| 3 years |
| William D. Tucker | M | - |
University of Virginia
| 1 years |
| Richard C. Kellogg | M | - |
University of Virginia
| 4 years |
| William Lee Matthes | M | - |
University of Virginia
| 4 years |
| Duane B. Hopper | M | 77 |
University of Virginia
| 4 years |
| Paul Hutchison Saunders | M | - |
University of Virginia
| 9 years |
| Jamie Polk | M | 81 |
University of Virginia
| 2 years |
| Ronald W. Tydings | M | - |
University of Virginia
| 4 years |
| Richard E. Anthony | M | 77 |
University of Virginia
| 2 years |
| Harold Jacobi | M | - |
University of Virginia
| 4 years |
| Larry N. Port | M | 73 |
University of Virginia
| 4 years |
| Joe Gazzoli | M | 71 |
University of Virginia
| 4 years |
| Marschall I. Smith | M | 79 |
University of Virginia
| 3 years |
| Bruce C. Galton | M | 72 |
University of Virginia
| 4 years |
| Steve P. Smiley | M | 75 |
University of Virginia
| 4 years |
| Paul J. Springman | M | 78 |
University of Virginia
| 4 years |
| William Sanders | M | 74 |
University of Virginia
| 4 years |
| Michael B. Goldberg | M | 77 |
University of Virginia
| 3 years |
| J. Marvin Quin | M | 76 |
University of Virginia
| 2 years |
| C. Faulders | M | 74 |
University of Virginia
| 4 years |
| Ravenel Boykin Curry | M | 83 |
University of Virginia
| 2 years |
| Gregory H. Olsen | M | - |
University of Virginia
| 3 years |
| Charles P. Baker | M | - |
University of Virginia
| 3 years |
| George A. Beller | M | - |
University of Virginia
| 3 years |
| Jack M. Stover | M | - |
University of Virginia
| 3 years |
| John L. Nau | M | - |
University of Virginia
| 4 years |
| Thomas V. Hildner | M | - |
University of Virginia
| 3 years |
| Weaver H. Gaines | M | - |
University of Virginia
| 4 years |
| Thurston R. Moore | M | - |
University of Virginia
| 4 years |
| Thomas B. Hoyt | M | - |
University of Virginia
| 4 years |
| Sandy Harris | M | - |
University of Virginia
| 4 years |
| Albert Richey | M | 75 |
University of Virginia
| 4 years |
| James S. Gilmore | M | 74 |
University of Virginia
| 4 years |
| Frank Armstrong | M | 80 |
University of Virginia
| 4 years |
| Al Berkeley | M | 80 |
University of Virginia
| 4 years |
| James H. Biggart | M | 71 |
University of Virginia
| 4 years |
| Joseph L. Manson | M | 74 |
University of Virginia
| 4 years |
| Benjamin C. Ackerly | M | - |
University of Virginia
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Henry Doggrell
- Personal Network
